In cancer cells, Kras mutations induce constitutive oncogenic activation, stimulating cell proliferation, suppressing apoptosis, altering cell metabolism, inducing autophagy, changing cell motility and invasion, and modulating the tumor microenvironment (Ferreira et al, 2022). This evidence concerns the gene KRAS and cancer.